Balchem Corporation to Participate in Baird's Global Industrial Conference
Balchem Corporation announced that its executive leadership team will participate in Baird's Global Industrial Conference on November 11, 2026.
Stocks · News reference
Balchem Corporation Reports Third Quarter 2026 Financial Results
Balchem Corporation announced its financial results for the third quarter ended September 30, 2026, reporting net sales of $290.7 million and net earnings of $46.7 million.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Balchem: 3 Key Takeaways for Long-Term Investors
Balchem reported record Q3 2026 sales of $291 million with 8.6% year-over-year growth. The company is expanding its science-backed specialty ingredients like VitaCholine and K2VITAL DELTA from infant nutrition into adult cognitive and cardiovascular markets. Proprietary encapsulation technology is driving adoption in animal nutrition, while a high-margin product mix is fueling segment profitability. The company achieved its 29th consecutive quarter of year-over-year adjusted EBITDA growth.
8-K filing — BALCHEM CORP (BCPC)
Filed: 2026-10-23 AccNo: 0000009326-26-000032 Size: 547 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits